LONDON (Reuters) - Japan's Daiichi Sankyo (T:4568) denied on Thursday it had received a takeover bid last year from British drugmaker AstraZeneca (L:AZN), as reported earlier by the online version of Nikkei Business.
"This is not the fact," the company said in a short statement.
AstraZeneca had earlier declined to comment on the report, which sent the Japanese group's share price soaring as much as 13 percent and triggered a trade suspension.